Corine Karema First Malaria World Congress 2018

Corine Karema

Corine Karema is the former Director of the Rwanda National Malaria Control Program (NMCP) where she served in this role for 10 years. From 2011 to May 2016, she was also the head of Malaria & Other Parasitic Diseases (Neglected tropical diseases) Division – Rwanda. She joined the NMCP in 2001 as head of the epidemiological surveillance/operational research. During her time at the NMCP, she led the development and implementation of malaria control strategies, policies and research, which has guided most of the evidence-based malaria control interventions in Rwanda. She has designed and led the impact evaluation of malaria control interventions showing important reductions in malaria morbidity and mortality in Rwanda She has a MD and MSc Epidemiology and has received training in malariology parasitology and epidemiology, laboratory biosafety, good clinical and laboratory practices for clinical trials and on planning and management of tropical diseases control programs. She is a graduate and faculty member of the Global Health Delivery Course at the University of Global Health Equity (UGHE). She is the Senior technical advisor at Quality and Equity Health care. Corine was also the Co–chair of the East African Roll Back Malaria Network Coordination committee from 2008-2014 and member of the Global Malaria Control and Elimination technical working group as well as of the Scientific Advisory Committee (SAC) for malaria policy and access of TDR/WHO Special Program. She was member of the WHO Drug Resistance and Containment Technical Expert Group, WHO Steering committee of the Global Technical Strategy for Malaria control and elimination 2016-2025 and RBM GMAP II Task Force. Corine is a PhD student at the Swiss Tropical and Public Health Institute at University of Basel, Switzerland. Corine serves as a malaria expert on the Global Fund Technical panel review for the 2017-2019 allocation periods. She is member of the member of the WHO Program Advisory Group of the RTS,S Malaria Vaccine Implementation Program , the Worldwide Antimalarial Resistance Network (WWARN) Scientific Advisory Committee (SAC) and the Lancet Commission on Malaria Eradication.

Abstracts this author is presenting: